Longevity & AgingAI Redesigns Yamanaka Factors to Reprogram Cells 50x More Efficiently Than Nature
Retro Biosciences partnered with OpenAI to redesign the proteins that turn adult cells back into stem cells — a process central to cellular rejuvenation and aging reversal. Using GPT-4b micro, their AI-engineered versions of Sox2 and Klf4 (two of the four Yamanaka factors) achieved 50 times greater efficiency than the naturally evolved proteins. This is a landmark result in regenerative medicine, suggesting AI can now outperform millions of years of biological evolution in targeted protein design. The interview, featuring Rico Meinl, Head of Applied AI at Retro Biosciences, covers how this collaboration unfolded, the protein design methodology, and what clinical applications might realistically emerge. For longevity enthusiasts, this signals that cellular reprogramming — once a theoretical tool — is rapidly becoming a precision technology.
